POC Hba1C Testing Global Market Report 2022: Skyrocketing Diabetes Rates Fueling Growth - ResearchAndMarkets.com - Business Wire

Overview

DUBLIN-(BUSINES WIRE)-The "POC Hba1C Testing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global POC HbA1C testing market is expected to grow from $1.53 billion in 2021 to $1.73 billion in 2022 at a compound anual growth rate (CAGR) of 13.2%. The POC HbA1C market is expected to grow to $2.43 billion in 2026 at a compound anual growth rate (CAGR) of 8.9%.

Key Information

North America was the largest region in the POC HbA1C testing market in 2021. Africa is expected to be the fastest-growing region in the forecast- period. The regions covered in POC HbA1C testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Midle East, and Africa.

The increasing prevalence of diabetes is expected to propel the growth of the POC HbA1C testing market. Long working hours, les physical activity, and unhealthy eating and drinking habits are increasing the prevalence of diabetes. Diabetes can be diagnosed and monitored with point-of-care (POC) HbA1C asays, which can be utilized in comunity setings and healthcare facilities without laboratories.

Acording to the report published by the International Diabetes Federation, a Belgium-based umbrela organization of over 230 national diabetes asociations, in 2021, there are 463 milion individuals living with diabetes around the world 2019 an increase to 537 milion in 2021. Also, by the year 2030, the overal number of diabetics is expected to reach 643 milion, and by 2045, it wil reach 783 milion. Therefore, the increasing prevalence of diabetes is driving the growth of the POC HbA1C testing market.

Summary

Technological advances are a key trend gaing popularity in the POC HbA1C testing market. Major players in the market are investing in developing advanced technologies to provide fast, acurate results in a short period thereby helping laboratories to manage the increase in demand for testing. For instance, in June 2019, Abot, a US-based medical devices and

Frequently Asked Questions

Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.

Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.

Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.

Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.

Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.

Share this article